Advertise
NEWSLETTER
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Juvenescence

Juvenescence advances aging drug to Phase 2 trial

Juvenescence expands into Abu Dhabi

FDA greenlights human trials of Serina’s Parkinson’s drug

Juvenescence acquires Ro5 to bolster AI drug discovery

Juvenescence lands $76m led by Abu Dhabi healthcare giant M42

M42 and Juvenescence collaborate on AI-enabled longevity drugs

Longevity investment bulletin: Cerevance, Frequency, Heartseed, Life Biosciences and more

Longevity investment bulletin: CohBar, Heartseed, Juvenescence and more

Juvenescence: Think aging up, rather than disease down

Juvenescence: Think aging up, rather than disease down

LyGenesis bags $19m to complete key clinical trial and advance cell therapy pipeline

LyGenesis bags $19m to complete key clinical trial and advance cell therapy pipeline

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form